Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Rajka M. Liscic"'
Autor:
Fabiola De Marchi, Ivana Munitic, Lea Vidatic, Eliša Papić, Valentino Rački, Jerneja Nimac, Igor Jurak, Gabriela Novotni, Boris Rogelj, Vladimira Vuletic, Rajka M. Liscic, Jason R. Cannon, Emanuele Buratti, Letizia Mazzini, Silva Hecimovic
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2793 (2023)
Many potential immune therapeutic targets are similarly affected in adult-onset neurodegenerative diseases, such as Alzheimer’s (AD) disease, Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD), as wel
Externí odkaz:
https://doaj.org/article/473fce8945424961988b168cd6f23534
Publikováno v:
Parkinson's Disease, Vol 2017 (2017)
Externí odkaz:
https://doaj.org/article/50c749de494942e6aab79089de149529
Publikováno v:
The Scientific World Journal, Vol 2014 (2014)
Externí odkaz:
https://doaj.org/article/9f7b752acef846998cd3d94f204a7edc
Publikováno v:
Brain Science Advances. 8:210-220
Age is recognized as the major factors of dementia, especially in for Alzheimer’s disease (AD). Given to the aged population, the increased number of demented population has been receiving a great impact in our society. Unfortunately, so far, no cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37f5e332b9bb89f0822db1e477b1e7b1
https://doi.org/10.26599/bsa.2022.9050019
https://doi.org/10.26599/bsa.2022.9050019
Publikováno v:
Brain Science Advances. 5:82-93
Current treatment paradigm in Alzheimer’s disease (AD) involves multiple approaches combining pharmacological and nonpharmacological intervention to mitigate the clinical symptoms, slow the progressive loss of cognitive and functional abilities, or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc21cfb35f486a392dc4991e11e1bf7
https://doi.org/10.1177/2096595820902580
https://doi.org/10.1177/2096595820902580
Publikováno v:
Molecular Neurodegeneration
Molecular Neurodegeneration, Vol 15, Iss 1, Pp 1-17 (2020)
Molecular Neurodegeneration, Vol 15, Iss 1, Pp 1-17 (2020)
Amyotrophic lateral sclerosis (ALS) and Frontotemporal Degeneration (FTD) are neurodegenerative disorders, related by deterioration of motor and cognitive functions and short survival. Aside from cases with an inherited pathogenic mutation, the cause
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e1a9ab04068eb8610542820c2a6e47
https://pubmed.ncbi.nlm.nih.gov/32487123
https://pubmed.ncbi.nlm.nih.gov/32487123
Autor:
Rajka M. Liscic
Publikováno v:
Archives of Industrial Hygiene and Toxicology. 66:285-290
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative disorders, related by signs of deteriorating motor and cognitive functions, and short survival. The cause is unknown and no effective treatment currently exis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34671d677edb9f7867dcd807f2c438da
https://doi.org/10.1515/aiht-2015-66-2679
https://doi.org/10.1515/aiht-2015-66-2679
Publikováno v:
Parkinson's Disease
Parkinson's Disease, Vol 2017 (2017)
Parkinson's Disease, Vol 2017 (2017)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26af011f6388e06735888a9148a79909
https://pubmed.ncbi.nlm.nih.gov/28352489
https://pubmed.ncbi.nlm.nih.gov/28352489
Autor:
Rajka M. Liscic
Publikováno v:
Archives of Industrial Hygiene and Toxicology. 64:603-608
Alzheimer’s dementia (AD) is the most common form of dementia among the elderly, accounting for at least two-thirds of all dementia cases. It represents a costly burden, since its global prevalence is estimated at 24 million cases. Amyloid beta or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e20c420c9b9d7b7a64b58ee2953695
https://doi.org/10.2478/10004-1254-64-2013-2414
https://doi.org/10.2478/10004-1254-64-2013-2414
Autor:
Rajka M. Liscic
Publikováno v:
European journal of pharmacology. 817
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are neurodegenerative disorders, related by signs of deteriorating motor and cognitive functions, and short survival. The causes are still largely unknown and no effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::671707547fac4cbcf480ecd2cff7abf8
https://pubmed.ncbi.nlm.nih.gov/29031901
https://pubmed.ncbi.nlm.nih.gov/29031901